July 10, 2019

Tony Award-Winner Laura Benanti to headline 24th Symphony at Salk

Noticias del Instituto Salk


Tony Award-Winner Laura Benanti to headline 24th Symphony at Salk

La Jolla — The Salk Institute will celebrate 24 years of Symphony at Salk, its annual concert under the stars, with the sounds of Tony Award-winner Laura Benanti and the acclaimed San Diego Symphony on Saturday, August 24.

Laura Benanti
For tickets: www.salk.edu/symphony

Photo Credit: Jenny Anderson

The gala evening concert will showcase Benanti, a five-time Tony Award nominee, singer and stage and screen actress. Currently starring as Eliza Doolittle in Lincoln’s Center’s revival of My Fair Lady, Benanti won the 2008 Tony Award for Outstanding Featured Actress in a Musical for her portrayal of Rose Lee in the Broadway revival of Gypsy.

“It’s my pleasure to take part in this magical evening that will benefit Salk’s world-renowned research into biology and disease,” Benanti says. “It’s an honor to perform under the stars on the Institute’s historic grounds with the lauded San Diego Symphony.”

Individual tickets for Symphony at Salk are $450 and include a champagne reception and gourmet dinner along with immersive entertainment set in the ambiance of the Louis Kahn-designed architectural landmark overlooking the Pacific.

All proceeds support the Salk Institute’s wide-ranging scientific inquiries, which have yielded more than 50 years of life-changing discoveries, as well as Salk’s award-winning educational outreach program, which has helped generations of students discover their passion for research and explore careers in science.

Tickets are on sale now and can be purchased at www.salk.edu/symphony. For more information, call 858-597-0657.

Para más información

Oficina de Comunicaciones
Tel.: (858) 453-4100
press@salk.edu

El Instituto Salk de Estudios Biológicos:

El Instituto Salk es un centro de investigación independiente y sin fines de lucro fundado en 1960 por Jonas Salk, creador de la primera vacuna segura y eficaz contra la poliomielitis. La misión del Instituto es impulsar una investigación fundamental, colaborativa y audaz que aborde los retos más acuciantes de la sociedad, entre ellos el cáncer, la enfermedad de Alzheimer y la vulnerabilidad agrícola. Esta ciencia fundamental sustenta todos los esfuerzos traslacionales, generando conocimientos que permiten el desarrollo de nuevos medicamentos e innovaciones en todo el mundo.